1. Home
  2. FBIN vs ADPT Comparison

FBIN vs ADPT Comparison

Compare FBIN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

SELL

Current Price

$47.98

Market Cap

4.8B

ML Signal

SELL

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

SELL

Current Price

$28.25

Market Cap

4.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FBIN
ADPT
Founded
1988
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.5B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
FBIN
ADPT
Price
$47.98
$28.25
Analyst Decision
Buy
Strong Buy
Analyst Count
20
8
Target Price
★ $49.06
$32.57
AVG Volume (30 Days)
★ 2.8M
2.0M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 2.18%
N/A
EPS Growth
N/A
★ 63.89
EPS
★ 0.43
N/A
Revenue
★ $4,463,200,000.00
$276,976,000.00
Revenue This Year
N/A
$10.85
Revenue Next Year
N/A
$21.60
P/E Ratio
$111.02
★ N/A
Revenue Growth
N/A
★ 54.77
52 Week Low
$32.34
$12.00
52 Week High
$64.84
$32.21

Technical Indicators

Market Signals
Indicator
FBIN
ADPT
Relative Strength Index (RSI) 59.92 53.42
Support Level $36.96 $24.02
Resistance Level $53.86 $29.92
Average True Range (ATR) 2.17 1.77
MACD -0.01 0.12
Stochastic Oscillator 55.43 46.56

Price Performance

Historical Comparison
FBIN
ADPT

About FBIN Fortune Brands Innovations Inc.

Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: